Commercializing products in the musculoskeletal segment of the marketplace - Adam Gridley, President and CEO, Histogenics Corp 00:00:00
Histogenics is a leading regenerative medicine company developing and commercializing novel tissue therapies that may offer more rapid and durable recoveries for patients with pain and loss of function due to musculoskeletal conditions.